Both contain identical tirzepatide at the same doses (2.515 mg weekly SC) but differ in FDA-approved indication
Nausea, stomach pain, and diarrhea might improve as your body gets used to the medication
"Understanding how weight changes, side effects, and income relate to treatment discontinuation and reinitiation can inform clinical and policy strategies to ensure equitable access to GLP-1 RAs for patients who need them." "Improved understanding of the factors related to discontinuation and reinitiation of GLP-1RAs is essential for personalizing treatment to each patient's unique health needs and circumstances, said Ty J
Mietlicki-Baase et al., 2015)
4 Although these findings are promising, randomized clinical trials are needed to clarify the potential efficacy of GLP-1 RAs for AUD and SUD treatment
Influences pineal gland and circadian regulation research: Epithalon originates from research on epithalamin, associated with pineal gland activity